reported that tumor mutation burden (TMB) and PD-L1 expression had limited predictive power across the IMvigor210 (mUC), POPLAR, and IMmotion150 (RCC) cohorts, whereas RNA-seq-based models captured their effects more accurately (6). Here, CD274 is linked to neoplasm.